Gsa Capital Partners LLP Icosavax, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.43 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
BUY
$7.22 - $10.05 $184,961 - $257,460
25,618 New
25,618 $198,000
Q4 2022

Feb 13, 2023
BUY
$2.32 - $10.97 $52,531 - $248,393
22,643 Added 78.44%
51,509 $409,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $9.21 $89,195 - $265,855
28,866 New
28,866 $91,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email